Generated by All in One SEO v4.9.7.2, this is an llms.txt file, used by LLMs to index the site.

# Terremoto

A seismic shift is coming to drug development & discovery.

## Sitemaps

- [XML Sitemap](https://terremotobio.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Terremoto Biosciences Closes $108 Million Series C Financing to Advance Selective AKT1-Inhibitors in Oncology and Hereditary Hemorrhagic Telangiectasia](https://terremotobio.com/press-release/terremoto-biosciences-closes-108-million-series-c-financing-to-advance-selective-akt1-inhibitors-in-oncology-and-hereditary-hemorrhagic-telangiectasia/)
- [Terremoto Biosciences Granted FDA Fast Track Designation for TER-2013, an AKT1-Selective Small Molecule Inhibitor for Breast Cancer](https://terremotobio.com/press-release/terremoto-biosciences-granted-fda-fast-track-designation-for-ter-2013-an-akt1-selective-small-molecule-inhibitor-for-breast-cancer/)
- [Business Insider | Meet the 23 biotech startups that are set to take off in the next 12 months, according to top VCs](https://www.businessinsider.com/list-top-biotech-startups-vcs-investors-new-companies-2022-7/#new_tab)
- [Endpoints | Exclusive: After selling Mirati to BMS for nearly $5B, Chuck Baum lands at another ‘undruggable’ company](https://endpoints.news/exclusive-after-selling-mirati-to-bms-for-nearly-5b-chuck-baum-lands-at-another-undruggable-company/#new_tab)
- [Endpoints | OrbiMed and Third Rock’s Terremoto Biosciences raises $175M for small molecule R&D](https://endpoints.news/orbimed-and-third-rocks-terremoto-biosciences-raises-175m-for-small-molecule-rd/#new_tab)
- [Endpoints | Former Principia team looks to shake up covalent small molecules again, this time at 'earthquake' scale](https://endpts.com/former-principia-team-looks-to-shake-up-covalent-small-molecules-again-this-time-at-earthquake-scale/#new_tab)
- [Wall Street Journal Venture Capital | Biotech Startups Seeking to Boost New Drug Targets Win Venture Funding](https://www.wsj.com/articles/biotech-startups-seeking-to-boost-new-drug-targets-win-venture-funding-11653559207#new_tab)
- [Terremoto Biosciences Appoints James Christensen, Ph.D., as President, Head of Research & Development](https://terremotobio.com/press-release/terremoto-biosciences-appoints-james-christensen-ph-d-as-president-head-of-research-development/)
- [Terremoto Biosciences Appoints Charles Baum, M.D., Ph.D., as Chief Executive Officer](https://terremotobio.com/press-release/terremoto-biosciences-appoints-charles-baum-m-d-ph-d-as-chief-executive-officer/)
- [Terremoto Biosciences Closes $175 Million Series B Financing](https://terremotobio.com/press-release/terremoto-biosciences-closes-175-million-series-b-financing/)
- [Buyer/Planner](https://terremotobio.com/careers/buyer-planner/)
- [Senior Research Associate/Associate Scientist, In Vivo Pharmacology](https://terremotobio.com/careers/senior-research-associate-associate-scientist-in-vivo-pharmacology/)
- [Associate Director/Director DMPK](https://terremotobio.com/careers/associate-director-director-dmpk/)
- [Terremoto Biosciences Launches With $75 Million Series A Financing and Mission to Discover and Develop Groundbreaking Covalent Medicines](https://terremotobio.com/press-release/terremoto-biosciences-launches-with-75-million-series-a-financing-and-mission-to-discover-and-develop-groundbreaking-covalent-medicines/)
- [Senior Research Associate/Associate Scientist, Cell Biology](https://terremotobio.com/careers/senior-research-associate-associate-scientist-cell-biology/)

## Pages

- [Home](https://terremotobio.com/) - By unleashing the power of covalent chemistry, we can deliver superior small molecule medicines with enhanced therapeutic benefit.
- [Expanded Access Policy](https://terremotobio.com/expanded-access-policy/)
- [News](https://terremotobio.com/news/) - Catch up with the latest happenings at Terremoto.
- [General Privacy Notice](https://terremotobio.com/privacy/privacy-policy/)
- [Job Applicant, Contractor, and Employee Privacy Notice](https://terremotobio.com/privacy/privacy-notice/)
- [Healthcare and Patient Privacy Notice](https://terremotobio.com/privacy/hcp-patient-privacy-notice/)
- [Consumer Health Information Privacy Notice](https://terremotobio.com/privacy/consumer-privacy-notice/)
- [Privacy](https://terremotobio.com/privacy/)
- [About](https://terremotobio.com/about/) - At Terremoto, we are creating a seismic shift in the breadth of pursuable targets. Our ultimate goal? To deliver highly targeted, small molecule medicines with optimized clinical profiles and superior therapeutic benefit.
- [Footer](https://terremotobio.com/footer/)
- [Careers](https://terremotobio.com/careers/) - While the Terremoto team is driven to unlock the power of covalent chemistry, we strive to explore new landscapes and support each other along the way.
- [Pipeline](https://terremotobio.com/pipeline/) - With our scientific approach, we have the potential to dramatically expand the universe of drug targets, as well as significantly improve upon existing medicines.
- [Science](https://terremotobio.com/science/) - With our scientific approach, we have the potential to dramatically expand the universe of drug targets, as well as significantly improve upon existing medicines.
- [Contact](https://terremotobio.com/contact/) - Get in touch with us today. 230 East Grand Avenue, Suite 200, San Francisco, CA, 94080
- [Privacy Policy](https://terremotobio.com/privacy-policy/)
- [IACUC Animal Welfare Reporting](https://terremotobio.com/animal-welfare/)
- [Terms of Use](https://terremotobio.com/terms-of-use/)

## Portfolio Items

- [Subhamoy Das, Ph.D.](https://terremotobio.com/team/subhamoy-das/)
- [Sarah Schisla](https://terremotobio.com/team/sarah-schisla/)
- [Janaina Dargell](https://terremotobio.com/team/janaina-dargell/)
- [Matthew Condakes, Ph.D.](https://terremotobio.com/team/matthew-condakes/)
- [Terri Schoeneman](https://terremotobio.com/team/terri-schoeneman/)
- [Paul Stephensen](https://terremotobio.com/team/paul-stephensen/)
- [Hamlet Chu, Ph.D.](https://terremotobio.com/team/hamlet-chu/)
- [Ronald Shazer, M.D., MBA](https://terremotobio.com/team/ronald-shazer/)
- [Jack Taunton, Ph.D.](https://terremotobio.com/team/jack-taunton-ph-d/)
- [Matthew Jacobson, Ph.D.](https://terremotobio.com/team/matthew-jacobson/)
- [Peter Thompson, M.D.](https://terremotobio.com/team/peter-thompson/)
- [Peter Thompson, M.D.](https://terremotobio.com/team/peter-thompson-m-d/)
- [Reid Huber, Ph.D.](https://terremotobio.com/team/reid-huber-ph-d/)
- [Reid Huber, Ph.D.](https://terremotobio.com/team/reid-huber/)
- [Romel Montellano, MBA](https://terremotobio.com/team/romel-montellano/)
- [Nikhil Loka, Ph.D.](https://terremotobio.com/team/nikhil-loka/)
- [Michael Corbett, Ph.D.](https://terremotobio.com/team/michael-corbett/)
- [Curtis Chin, M.D., Ph.D.](https://terremotobio.com/team/curtis-chin/)
- [John Link, Ph.D.](https://terremotobio.com/team/john-link-ph-d/)
- [Daniel O’Connell, M.D., Ph.D.](https://terremotobio.com/team/daniel-oconnell-m-d-ph-d/)
- [Wagner Silva](https://terremotobio.com/team/wagner-silva/)
- [Renee Himes](https://terremotobio.com/team/renee-himes/)
- [Noleen Bonfante](https://terremotobio.com/team/noleen-bonfante/)
- [Mark Eskes](https://terremotobio.com/team/mark-eskes/)
- [Maika Adair](https://terremotobio.com/team/maika-adair/)
- [Charles Baum, M.D., Ph.D.](https://terremotobio.com/team/charles-baum-ceo/)
- [James Christensen, Ph.D.](https://terremotobio.com/team/james-christensen-ph-d-3/)
- [Adam Zajdlik](https://terremotobio.com/team/adam-zajdlik/)
- [Johnson Nguyen](https://terremotobio.com/team/johnson-nguyen/)
- [James Christensen, Ph.D.](https://terremotobio.com/team/james-christensen-ph-d-2/)
- [Jane Shank](https://terremotobio.com/team/jane-shank/)
- [Nicola Stagg, Ph.D., DABT](https://terremotobio.com/team/nicola-stagg/)
- [Charles Baum, M.D., Ph.D.](https://terremotobio.com/team/charles-baum-ph-d/)
- [George Gindoyan](https://terremotobio.com/team/george-gindoyan/)
- [Jessica Sun, Ph.D.](https://terremotobio.com/team/jessica-sun/)
- [Kevin Koch, Ph.D.](https://terremotobio.com/team/kevin-koch-ph-d/)

## Categories

- [Press Release](https://terremotobio.com/category/press-release/)
- [2022](https://terremotobio.com/category/press-release/2022-press-release/)
- [Careers](https://terremotobio.com/category/careers/)
- [Home-Media](https://terremotobio.com/category/home-media/)
- [2023](https://terremotobio.com/category/press-release/2023-press-release/)
- [2024](https://terremotobio.com/category/press-release/2024-press-release/)
- [2025](https://terremotobio.com/category/press-release/2025-press-release/)
- [2026](https://terremotobio.com/category/press-release/2026-press-release/)

## Portfolio Categories

- [Leadership](https://terremotobio.com/team/leadership/)
- [BOD](https://terremotobio.com/team/bod/)
- [Scientific Advisors](https://terremotobio.com/team/scientific-advisors/)
- [Has_Bio](https://terremotobio.com/team/has_bio/)